CD30 Recombinant Rabbit mAb (SDT-216-2)

產(chǎn)品型號(hào)：S0B2183

更新時(shí)間：2025-07-13

廠商性質(zhì)：生產(chǎn)廠家

訪問(wèn)量：36

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

HA標(biāo)簽重組兔單抗具有增強(qiáng)蛋白定位的能力

FGF19信號(hào)通路：從代謝調(diào)控到癌癥治療

葉酸受體α在癌癥治療策略中的多面性

PLA技術(shù)+蛋白翻譯后修飾（PTMs）研究，蛋白研究新CP！

產(chǎn)品介紹

CD30 is a transmembrane protein from the tumour necrosis factor receptor superfamily. It is expressed on a small subset of activated T and B lymphocytes, and various lymphoid neoplasms. CD30 is a particularly treatment target because its levels are high in tumours but low in healthy tissues. Several therapeutic strategies targeting CD30 have been developed, including monoclonal antibodies, conjugated antibodies （combination of brentuximab vedotin with chemotherapy or immunotherapy）, bispecific antibodies and cell and gene therapies, such as anti-CD30 CAR-T cells in particular [PMID: 37170397

].

上一個(gè)：S0B2182SOX9 Recombinant Rabbit mAb (SDT-019-29)